Status:
COMPLETED
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborating Sponsors:
University of Pennsylvania
Conditions:
Opioid-Related Disorders
Substance-Related Disorders
Eligibility:
All Genders
21-59 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine the safety of lofexidine in the treatment of opiate withdrawal. Preliminary data will also be obtained to assess the ability of lofexidine to alleviate opiate...
Eligibility Criteria
Please contact site for information.
Key Trial Info
Start Date :
July 1 1996
Trial Type :
INTERVENTIONAL
End Date :
December 1 1997
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000354
Start Date
July 1 1996
End Date
December 1 1997
Last Update
January 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104 6178